Pfizer CEO Albert Bourla talked to French News outlets and stated that he thinks C-19 will remain with us for years, but the future waves won’t pass with many restrictions, and our lives will return to normal around spring.
Bourla, in an interview with LeFigaro, stated that he expects a return to normal life around spring, with the caveat that the dynamic of C-19 mutations and spread cloud the accuracy of any predictions.
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
The Pfizer CEO credited developments in C-19 testing, shots, and therapeutics for the optimistic outlook and said that he thinks Omicron will be the last mutation with so many restrictions.
“This is a virus that has spread all over the world, so it is very difficult to get rid of,” Bourla told BFM TV.
He stated that Pfizer wants to invest half a billion dollars in France over the next five years to improve global production of its C-19 pill Paxlovid.
“We are honored by this renewed proof of confidence, Pfizer being a long-time customer of Novasep, and we are of course proud to contribute to the manufacturing of this medicine which has shown in clinical trials to have a positive impact on hospitalization among at-risk COVID-19 patients,” Novasep CEO Dr. Michel Spagnol said in a statement.
Clinical trials have shown that Paxlovid is 90% effective in preventing hospitalizations and deaths in patients at high risk of serious illness.
Novasep expects its facility in Mourenx, France will be incorporated into Pfizer’s growing manufacturing network of suppliers by the third quarter of this year.